Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Magic Formula for Biotech
Motley Fool
Sunday, January 15, 2012 - 1:42pm
tags:
GSK responds to the recent court ruling on the COMPAS study in Mendoza, Argentina
PharmPro
Sunday, January 15, 2012 - 1:41pm
tags:
GSK, Synflorix, vaccines
How Does Amgen Boost Its Returns?
Motley Fool
Sunday, January 15, 2012 - 1:37pm
tags:
Amgen
Warning: Don't Sell on This News (Seattle Genetics)
Motley Fool
Sunday, January 15, 2012 - 1:36pm
tags:
Seattle Genetics, progressive multifocal leukoencephalopathy, PML, Adcetris
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market
BioMedReports
Saturday, January 14, 2012 - 1:00pm
tags:
Nuron Biotech, Mitsubishi Tanabe Pharma, HibTITER, vaccines, flu vaccines
Kedem Pharma begins development of anti-cancer drug, Gleevec
Pharmabiz
Saturday, January 14, 2012 - 12:37pm
tags:
Kedem Pharmaceuticals, Gleevec, chronic myeloid leukemia
Is Teva Pharmaceutical a Buffett Stock?
Motley Fool
Saturday, January 14, 2012 - 12:34pm
tags:
Teva Pharmaceuticals
After tightening focus, Akorn takes off
Chicago Tibune, IL
Saturday, January 14, 2012 - 12:34pm
tags:
Akorn
Biosimilars: The Next Big Thing
Zacks
Saturday, January 14, 2012 - 12:30pm
tags:
biosimilars
Say Yes to Novartis
Barron's
Saturday, January 14, 2012 - 12:29pm
tags:
Novartis
Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders
Pipeline Review
Saturday, January 14, 2012 - 12:21pm
tags:
Cimzia, Otsuka, UCB Pharmaceuticals
3 Good Undervalued Bio-Pharma Speculation Buys
Seeking Alpha
Saturday, January 14, 2012 - 12:19pm
tags:
Ampio Pharmaceuticals, Geron, Antares Pharma
Novo Nordisk: Increasing Diabetes Rate Should Benefit This Danish Pharmaceutical
Seeking Alpha
Saturday, January 14, 2012 - 12:17pm
tags:
Novo Nordisk, diabetes
BioDelivery Science: A Pipeline Rejuvenated
Seeking Alpha
Saturday, January 14, 2012 - 12:13pm
tags:
BioDelivery Sciences
Sales of Lipitor Are Leveling Off
New York Times
Saturday, January 14, 2012 - 12:11pm
tags:
Pfizer, Lipitor, generics
Keeping An Eye On Isis
Seeking Alpha
Saturday, January 14, 2012 - 12:08pm
tags:
Isis Pharmaceuticals, antisense, proteomes
Nestle Said to Vie With Danone in Bids to Acquire Pfizer’s Baby-Food Unit
Bloomberg
Saturday, January 14, 2012 - 11:57am
tags:
Pfizer
Novartis Excedrin recall expands into Canada
Yahoo/AP
Saturday, January 14, 2012 - 11:56am
tags:
Novartis, Excedrin, recalls
J&J Marketed Risperdal to Kids Despite Warnings, Jurors Told
Bloomberg
Saturday, January 14, 2012 - 11:55am
tags:
JNJ, Risperdal
Ventrus Announces Publication of Prior Phase 2b Study on the Safety and Efficacy of Iferanserin in the Treatment of Hemorrhoid Disease
Yahoo/Globe NewsWire
Saturday, January 14, 2012 - 11:54am
tags:
Ventrus, iferanserin, hemorrhoids

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.